Edwards Lifesciences Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | $0.64 | $0.64 | $0.64 |
| Q2 2024 | 5 | $0.69 | $0.69 | $0.69 |
| Q3 2024 | 14 | $0.66 | $0.67 | $0.66 |
| Q4 2024 | 17 | $0.54 | $0.56 | $0.55 |
| Q1 2025 | 13 | $0.54 | $0.67 | $0.59 |
| Q2 2025 | 9 | $0.59 | $0.63 | $0.61 |
| Q3 2025 | 10 | $0.60 | $0.64 | $0.62 |
| Q4 2025 | 11 | $0.60 | $0.65 | $0.63 |
| Q1 2026 | 10 | $0.62 | $0.66 | $0.64 |
| Q2 2026 | 11 | $0.66 | $0.71 | $0.69 |
| Q3 2026 | 5 | $0.67 | $0.72 | $0.70 |
| Q4 2026 | 5 | $0.67 | $0.72 | $0.70 |
Edwards Lifesciences Corporation Earnings Date And Information
Edwards Lifesciences Corporation last posted its earnings results on Thursday, October 24th, 2024. The company reported $0.67 earnings per share for the quarter, topping analysts' consensus estimates of $0.665 by $0.005. The company had revenue of 1.35 B for the quarter and had revenue of 6.00 B for the year. Edwards Lifesciences Corporation has generated $2 earnings per share over the last year ($2.3 diluted earnings per share) and currently has a price-to-earnings ratio of 9.49. Edwards Lifesciences Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based on prior year's report dates.
Edwards Lifesciences Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | $5.14 | $1.54 B | $1.35 B | ||
| 07/31/2024 | Q2 2024 | $0.61 | $1.65 B | $1.39 B | ||
| 04/29/2024 | Q1 2024 | $0.58 | $1.60 B | |||
| 02/12/2024 | Q4 2023 | $0.61 | $1.53 B | |||
| 10/27/2023 | Q3 2023 | $0.63 | $1.48 B | $1.48 B | ||
| 07/28/2023 | Q2 2023 | $0.51 | $1.51 B | $1.53 B | ||
| 04/28/2023 | Q1 2023 | $0.56 | $1.46 B | |||
| 02/13/2023 | Q4 2022 | $0.65 | $1.35 B | |||
| 10/28/2022 | Q3 2022 | $0.55 | $1.33 B | $1.32 B | ||
| 07/29/2022 | Q2 2022 | $0.65 | $1.40 B | $1.37 B | ||
| 04/28/2022 | Q1 2022 | $0.60 | $1.34 B | |||
| 02/14/2022 | Q4 2021 | $0.54 | $1.33 B | |||
| 10/29/2021 | Q3 2021 | $0.55 | $1.32 B | $1.31 B | ||
| 07/30/2021 | Q2 2021 | $0.79 | $1.28 B | $1.38 B | ||
| 04/28/2021 | Q1 2021 | $0.54 | $1.22 B | |||
| 02/12/2021 | Q4 2020 | $0.50 | $1.19 B | |||
| 10/23/2020 | Q3 2020 | $0.52 | $1.08 B | $1.14 B | ||
| 07/27/2020 | Q2 2020 | -$0.20 | $793.92 M | $925.00 M | ||
| 04/27/2020 | Q1 2020 | $0.50 | $1.13 B | |||
| 02/14/2020 | Q4 2019 | $0.45 | $1.17 B |
Edwards Lifesciences Corporation Earnings: Frequently Asked Questions
-
When is Edwards Lifesciences Corporation's earnings date?
Edwards Lifesciences Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates.
-
Did Edwards Lifesciences Corporation beat their earnings estimates last quarter?
In the previous quarter, Edwards Lifesciences Corporation (:EW) reported $0.67 earnings per share (EPS) to beat the analysts' consensus estimate of $0.665 by $0.005.
-
How can I listen to Edwards Lifesciences Corporation's earnings conference call?
The conference call for Edwards Lifesciences Corporation's latest earnings report can be listened to online.
-
How can I read Edwards Lifesciences Corporation's conference call transcript?
The conference call transcript for Edwards Lifesciences Corporation's latest earnings report can be read online.
-
How much revenue does Edwards Lifesciences Corporation generate each year?
Edwards Lifesciences Corporation (:EW) has a recorded annual revenue of $6.00 B.
-
How much profit does Edwards Lifesciences Corporation generate each year?
Edwards Lifesciences Corporation (:EW) has a recorded net income of $6.00 B. Edwards Lifesciences Corporation has generated $2.31 earnings per share over the last four quarters.
-
What is Edwards Lifesciences Corporation's price-to-earnings ratio?
Edwards Lifesciences Corporation (:EW) has a price-to-earnings ratio of 9.49 and price/earnings-to-growth ratio is 0.05.
